Effectiveness, Efficacy, and Safety of XGEVA (denosumab) in Chinese Patients With Giant Cell Tumor of Bone (GCTB): A Systematic Literature Review (20220044)

First published 28/09/2022

Last updated 05/12/2023

EU PAS number:

EUPAS49061

Study

Finalised

Documents

Study protocol

Initial protocol

Protocol-Published Original denosumab 20220044

English (489.33 KB - PDF) View document

Study results

20220044_ORSR Abstract_28MAR2023_Redacted

English (104.26 KB - PDF) View document

Study report

Other information

Secondary tabs